{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:31:01Z","timestamp":1791491461182,"version":"4.3.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11934-024-01238-0","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T09:07:19Z","timestamp":1726650439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Advancements in Understanding and Managing Radiation Cystitis: A Comprehensive Review"],"prefix":"10.1007","volume":"26","author":[{"given":"Emily","family":"Neckonoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"issue":"Suppl 3","key":"1238_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bju.14145","volume":"121","author":"JL Ma","year":"2018","unstructured":"Ma JL, Hennessey DB, Newell BP, Bolton DM, Lawrentschuk N. Radiotherapy-related complications presenting to a urology department: a more common problem than previously thought? BJU Int. 2018;121(Suppl 3):28\u201332. https:\/\/doi.org\/10.1111\/bju.14145.","journal-title":"BJU Int"},{"issue":"1","key":"1238_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.prnil.2020.07.006","volume":"9","author":"F Sanguedolce","year":"2021","unstructured":"Sanguedolce F, Sancho Pardo G, Mercad\u00e9 Sanchez A, Bala\u00f1a Lucena J, Pisano F, Cortez JC, et al. Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies. Prostate Int. 2021;9(1):48\u201353. https:\/\/doi.org\/10.1016\/j.prnil.2020.07.006.","journal-title":"Prostate Int"},{"issue":"10","key":"1238_CR3","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s11255-023-03709-8","volume":"55","author":"R Chen","year":"2023","unstructured":"Chen R, Song S, Amasyali AS, Leu R, Shete K, Ritchie C, et al. Does renal failure worsen radiation cystitis following radical prostatectomy? Int Urol Nephrol. 2023;55(10):2439\u201345. https:\/\/doi.org\/10.1007\/s11255-023-03709-8.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1238_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41391-022-00520-x","volume":"26","author":"R David","year":"2023","unstructured":"David R, Buckby A, Kahokehr AA, Lee J, Watson DI, Leung J, et al. Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2023;26(1):8\u201315. https:\/\/doi.org\/10.1038\/s41391-022-00520-x.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"1238_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijrobp.2016.05.017","volume":"96","author":"G Sanguineti","year":"2016","unstructured":"Sanguineti G, Arcidiacono F, Landoni V, Saracino BM, Farneti A, Arcangeli S, et al. Macroscopic Hematuria after Conventional or Hypofractionated Radiation Therapy: results from a prospective phase 3 study. Int J Radiat Oncol Biol Phys. 2016;96(2):304\u201312. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.05.017.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1238_CR6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1097\/ju.0000000000002443","volume":"207","author":"WT Turchan","year":"2022","unstructured":"Turchan WT, Cutright D, Wu T, Leng JX, Dignam JJ, Eggener SE, et al. Hematuria following Post-prostatectomy Radiotherapy: incidence increases with Long-Term Followup. J Urol. 2022;207(6):1236\u201345. https:\/\/doi.org\/10.1097\/ju.0000000000002443.","journal-title":"J Urol"},{"issue":"10","key":"1238_CR7","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00345-022-04124-x","volume":"40","author":"RV David","year":"2022","unstructured":"David RV, Kahokehr AA, Lee J, Watson DI, Leung J, O\u2019Callaghan ME. Incidence of genitourinary complications following radiation therapy for localised prostate cancer. World J Urol. 2022;40(10):2411\u201322. https:\/\/doi.org\/10.1007\/s00345-022-04124-x.","journal-title":"World J Urol"},{"issue":"5","key":"1238_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1159\/000521723","volume":"107","author":"K Makino","year":"2023","unstructured":"Makino K, Sato Y, Takenaka R, Yamashita H, Akiyama Y, Yamada Y, et al. Cumulative incidence and clinical risk factors of Radiation Cystitis after Radiotherapy for prostate Cancer. Urol Int. 2023;107(5):440\u20136. https:\/\/doi.org\/10.1159\/000521723.","journal-title":"Urol Int"},{"issue":"5","key":"1238_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-j","volume":"31","author":"LB Marks","year":"1995","unstructured":"Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1257\u201380. https:\/\/doi.org\/10.1016\/0360-3016(94)00431-j.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1238_CR10","doi-asserted-by":"publisher","first-page":"346812","DOI":"10.1155\/2015\/346812","volume":"2015","author":"C Browne","year":"2015","unstructured":"Browne C, Davis NF, Mac Craith E, Lennon GM, Mulvin DW, Quinlan DM, et al. A narrative review on the pathophysiology and management for Radiation Cystitis. Adv Urol. 2015;2015:346812. https:\/\/doi.org\/10.1155\/2015\/346812.","journal-title":"Adv Urol"},{"issue":"2","key":"1238_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3909\/riu0700","volume":"18","author":"BM Zwaans","year":"2016","unstructured":"Zwaans BM, Nicolai HG, Chancellor MB, Lamb LE. Challenges and opportunities in Radiation-induced hemorrhagic cystitis. Rev Urol. 2016;18(2):57\u201365. https:\/\/doi.org\/10.3909\/riu0700.","journal-title":"Rev Urol"},{"issue":"8","key":"1238_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/s1470-2045(16)30102-4","volume":"17","author":"D Dearnaley","year":"2016","unstructured":"Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17(8):1047\u201360. https:\/\/doi.org\/10.1016\/s1470-2045(16)30102-4.","journal-title":"Lancet Oncol"},{"key":"1238_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.urology.2019.05.034","volume":"131","author":"SE Martin","year":"2019","unstructured":"Martin SE, Begun EM, Samir E, Azaiza MT, Allegro S, Abdelhady M. Incidence and morbidity of Radiation-Induced Hemorrhagic Cystitis in prostate Cancer. Urology. 2019;131:190\u20135. https:\/\/doi.org\/10.1016\/j.urology.2019.05.034.","journal-title":"Urology"},{"issue":"6","key":"1238_CR14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.euo.2021.07.005","volume":"4","author":"JN Staffurth","year":"2021","unstructured":"Staffurth JN, Haviland JS, Wilkins A, Syndikus I, Khoo V, Bloomfield D, et al. Impact of Hypofractionated Radiotherapy on patient-reported outcomes in prostate Cancer: results up to 5 year in the CHHiP trial (CRUK\/06\/016). Eur Urol Oncol. 2021;4(6):980\u201392. https:\/\/doi.org\/10.1016\/j.euo.2021.07.005.","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"1238_CR15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11547-018-0977-1","volume":"124","author":"B Detti","year":"2019","unstructured":"Detti B, Baki M, Becherini C, Saieva C, Scartoni D, Giacomelli I, et al. High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary\/gastrointestinal toxicity and outcomes, a single-institution experience. Radiol Med. 2019;124(5):422\u201331. https:\/\/doi.org\/10.1007\/s11547-018-0977-1.","journal-title":"Radiol Med"},{"issue":"5","key":"1238_CR16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-c","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341\u20136. https:\/\/doi.org\/10.1016\/0360-3016(95)00060-c.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1238_CR17","unstructured":"Institute NC. Common Terminology Criteria for Adverse Events (CTCAE). 2017."},{"issue":"6","key":"1238_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.urpr.2015.10.007","volume":"3","author":"JE Kiechle","year":"2016","unstructured":"Kiechle JE, Kim SP, Yu JB, Maurice MJ, Dong S, Cherullo EE, et al. Economic Burden Associated with hospitalization for Radiation Cystitis: results from a Statewide Inpatient database. Urol Pract. 2016;3(6):437\u201342. https:\/\/doi.org\/10.1016\/j.urpr.2015.10.007.","journal-title":"Urol Pract"},{"issue":"2","key":"1238_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/bju.15650","volume":"130","author":"V Lee","year":"2022","unstructured":"Lee V, An Y, Park HS, Yu JB, Kim SP, Jairam V. Emergency department visits for radiation cystitis among patients with a prostate cancer history. BJU Int. 2022;130(2):208\u201316. https:\/\/doi.org\/10.1111\/bju.15650.","journal-title":"BJU Int"},{"key":"1238_CR20","unstructured":"Neckonoff E, Marte J, Gorroochurn P, Joice GA, Anderson CB. National trends of Inpatient Radiation Cystitis: 2016\u20132019. Urology PracticeIn."},{"key":"1238_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16140","author":"KD Li","year":"2023","unstructured":"Li KD, Jones CP, Hakam N, Erickson BA, Vanni AJ, Chancellor MB, et al. Haemorrhagic cystitis: a review of management strategies and emerging treatments. BJU Int. 2023. https:\/\/doi.org\/10.1111\/bju.16140.","journal-title":"BJU Int"},{"key":"1238_CR22","doi-asserted-by":"publisher","unstructured":"Helissey C, Cavallero S, Brossard C, Dusaud M, Chargari C, Fran\u00e7ois S. Chronic inflammation and Radiation-Induced Cystitis: molecular background and therapeutic perspectives. Cells. 2020;10(1). https:\/\/doi.org\/10.3390\/cells10010021.","DOI":"10.3390\/cells10010021"},{"key":"1238_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urology.2018.07.025","volume":"120","author":"BMM Zwaans","year":"2018","unstructured":"Zwaans BMM, Bartolone SN, Chancellor MB, Nicolai HE, Lamb LE. Altered angiogenic growth factors in urine of prostate Cancer survivors with Radiation History and Radiation Cystitis. Urology. 2018;120:180\u20136. https:\/\/doi.org\/10.1016\/j.urology.2018.07.025.","journal-title":"Urology"},{"issue":"10","key":"1238_CR24","doi-asserted-by":"publisher","first-page":"e0241388","DOI":"10.1371\/journal.pone.0241388","volume":"15","author":"BMM Zwaans","year":"2020","unstructured":"Zwaans BMM, Nicolai HE, Chancellor MB, Lamb LE. Prostate cancer survivors with symptoms of radiation cystitis have elevated fibrotic and vascular proteins in urine. PLoS ONE. 2020;15(10):e0241388. https:\/\/doi.org\/10.1371\/journal.pone.0241388.","journal-title":"PLoS ONE"},{"issue":"27","key":"1238_CR25","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1200\/jco.21.02831","volume":"40","author":"AR Yeung","year":"2022","unstructured":"Yeung AR, Deshmukh S, Klopp AH, Gil KM, Wenzel L, Westin SN, et al. Intensity-modulated Radiation Therapy reduces patient-reported chronic toxicity compared with Conventional Pelvic Radiation Therapy: updated results of a phase III trial. J Clin Oncol. 2022;40(27):3115\u20139. https:\/\/doi.org\/10.1200\/jco.21.02831.","journal-title":"J Clin Oncol"},{"key":"1238_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.11.058","author":"LC Mendez","year":"2023","unstructured":"Mendez LC, Crook J, Martell K, Schaly B, Hoover DA, Dhar A, et al. Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well tolerated as conventionally fractionated WPRT in patients with prostate Cancer? Early results from the HOPE trial. Int J Radiat Oncol Biol Phys. 2023. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.058.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1238_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ctro.2017.09.005","volume":"6","author":"H Inokuchi","year":"2017","unstructured":"Inokuchi H, Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Nakamura K, et al. Correlation between urinary dose and delayed radiation cystitis after 78 gy intensity-modulated radiotherapy for high-risk prostate cancer: a 10-year follow-up study of genitourinary toxicity in clinical practice. Clin Transl Radiat Oncol. 2017;6:31\u20136. https:\/\/doi.org\/10.1016\/j.ctro.2017.09.005.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"1238_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijrobp.2023.11.048","volume":"119","author":"A Alexander","year":"2024","unstructured":"Alexander A, Gagne I, Bahl G, Kim D, Mestrovic A, Ye A, et al. Late toxicity of prostate Ultrahypofractionated Radiation Therapy compared with moderate hypofractionation in a Randomized Trial. Int J Radiat Oncol Biol Phys. 2024;119(1):110\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.048.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1238_CR29","doi-asserted-by":"publisher","first-page":"e14377","DOI":"10.14814\/phy2.14377","volume":"8","author":"BMM Zwaans","year":"2020","unstructured":"Zwaans BMM, Wegner KA, Bartolone SN, Vezina CM, Chancellor MB, Lamb LE. Radiation cystitis modeling: a comparative study of bladder fibrosis radio-sensitivity in C57BL\/6, C3H, and BALB\/c mice. Physiol Rep. 2020;8(4):e14377. https:\/\/doi.org\/10.14814\/phy2.14377.","journal-title":"Physiol Rep"},{"key":"1238_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euros.2021.01.016","volume":"26","author":"JP Redorta","year":"2021","unstructured":"Redorta JP, Sanguedolce F, Pardo GS, Romancik M, Vittori G, Minervini A, et al. Multicentre International Study for the Prevention with iAluRil of Radio-induced Cystitis (MISTIC): a Randomised Controlled Study. Eur Urol Open Sci. 2021;26:45\u201354. https:\/\/doi.org\/10.1016\/j.euros.2021.01.016.","journal-title":"Eur Urol Open Sci"},{"key":"1238_CR31","doi-asserted-by":"publisher","unstructured":"Helissey C, Guitard N, Th\u00e9ry H, Goulinet S, Mauduit P, Girleanu M, et al. Two new potential therapeutic approaches in Radiation Cystitis derived from mesenchymal stem cells: extracellular vesicles and conditioned medium. Biology (Basel). 2022;11(7). https:\/\/doi.org\/10.3390\/biology11070980.","DOI":"10.3390\/biology11070980"},{"key":"1238_CR32","doi-asserted-by":"crossref","unstructured":"Abramowitz DJ, Warner JN. Clinical management of radiation cystitis: a narrative review. AME Med J. 2021;6.","DOI":"10.21037\/amj-20-169"},{"issue":"6","key":"1238_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/imj.12447","volume":"44","author":"JG Jin","year":"2014","unstructured":"Jin JG. High-dose methylprednisolone is effective in treating radiation-induced refractory haemorrhagic cystitis. Intern Med J. 2014;44(6):615\u20137. https:\/\/doi.org\/10.1111\/imj.12447.","journal-title":"Intern Med J"},{"issue":"2","key":"1238_CR34","first-page":"145","volume":"2","author":"EB Lander","year":"2014","unstructured":"Lander EB, See JR. Intravesical instillation of pentosan polysulfate encapsulated in a liposome nanocarrier for interstitial cystitis. Am J Clin Exp Urol. 2014;2(2):145\u20138.","journal-title":"Am J Clin Exp Urol"},{"issue":"2","key":"1238_CR35","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.21037\/tcr-20-2589","volume":"10","author":"J Chorbi\u0144ska","year":"2021","unstructured":"Chorbi\u0144ska J, Krajewski W, Zdrojowy R. Urological complications after radiation therapy-nothing ventured, nothing gained: a Narrative Review. Transl Cancer Res. 2021;10(2):1096\u2013118. https:\/\/doi.org\/10.21037\/tcr-20-2589.","journal-title":"Transl Cancer Res"},{"issue":"6","key":"1238_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1464-410X.2004.05044.x","volume":"94","author":"SS Sandhu","year":"2004","unstructured":"Sandhu SS, Goldstraw M, Woodhouse CR. The management of haemorrhagic cystitis with sodium pentosan polysulphate. BJU Int. 2004;94(6):845\u20137. https:\/\/doi.org\/10.1111\/j.1464-410X.2004.05044.x.","journal-title":"BJU Int"},{"key":"1238_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/rru.S320684","volume":"15","author":"FA Jefferson","year":"2023","unstructured":"Jefferson FA, Linder BJ. Hemorrhagic cystitis: making Rapid and Shrewd Clinical and Surgical decisions for improving patient outcomes. Res Rep Urol. 2023;15:291\u2013303. https:\/\/doi.org\/10.2147\/rru.S320684.","journal-title":"Res Rep Urol"},{"key":"1238_CR38","unstructured":"Health, NIo. ELMIRON- pentosan polysulfate sodium capsule, gelatin coated. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=f0ba651e-3d8a-11df-8fbe-119855d89593 (2022). Accessed."},{"issue":"2","key":"1238_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.radonc.2004.05.007","volume":"73","author":"V Veerasarn","year":"2004","unstructured":"Veerasarn V, Khorprasert C, Lorvidhaya V, Sangruchi S, Tantivatana T, Narkwong L, et al. Reduced recurrence of late hemorrhagic radiation cystitis by WF10 therapy in cervical cancer patients: a multicenter, randomized, two-arm, open-label trial. Radiother Oncol. 2004;73(2):179\u201385. https:\/\/doi.org\/10.1016\/j.radonc.2004.05.007.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1238_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0022-5347(17)39361-8","volume":"144","author":"YK Liu","year":"1990","unstructured":"Liu YK, Harty JI, Steinbock GS, Holt HA, Goldstein DH, Amin M. Treatment of Radiation or Cyclophosphamide Induced Hemorrhagic Cystitis using conjugated estrogen. J Urol. 1990;144(1):41\u20133. https:\/\/doi.org\/10.1016\/S0022-5347(17)39361-8.","journal-title":"J Urol"},{"issue":"5","key":"1238_CR41","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/s0022-5347(17)35249-7","volume":"151","author":"J Miller","year":"1994","unstructured":"Miller J, Burfield GD, Moretti KL. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol. 1994;151(5):1348\u201350. https:\/\/doi.org\/10.1016\/s0022-5347(17)35249-7.","journal-title":"J Urol"},{"issue":"4","key":"1238_CR42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/bju.14516","volume":"123","author":"C Pascoe","year":"2019","unstructured":"Pascoe C, Duncan C, Lamb BW, Davis NF, Lynch TH, Murphy DG, et al. Current management of radiation cystitis: a review and practical guide to clinical management. BJU Int. 2019;123(4):585\u201394. https:\/\/doi.org\/10.1111\/bju.14516.","journal-title":"BJU Int"},{"key":"1238_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajem.2023.03.020","volume":"68","author":"H Choi","year":"2023","unstructured":"Choi H, Kim DW, Jung E, Kye YC, Lee J, Jo S, et al. Impact of intravesical administration of tranexamic acid on gross hematuria in the emergency department: a before-and-after study. Am J Emerg Med. 2023;68:68\u201372. https:\/\/doi.org\/10.1016\/j.ajem.2023.03.020.","journal-title":"Am J Emerg Med"},{"issue":"21","key":"1238_CR44","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","volume":"386","author":"PJ Devereaux","year":"2022","unstructured":"Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, et al. Tranexamic acid in patients undergoing noncardiac surgery. N Engl J Med. 2022;386(21):1986\u201397. https:\/\/doi.org\/10.1056\/NEJMoa2201171.","journal-title":"N Engl J Med"},{"issue":"9","key":"1238_CR45","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1046\/j.1464-410x.2000.00900.x","volume":"86","author":"SK Choong","year":"2000","unstructured":"Choong SK, Walkden M, Kirby R. The management of intractable haematuria. BJU Int. 2000;86(9):951\u20139. https:\/\/doi.org\/10.1046\/j.1464-410x.2000.00900.x.","journal-title":"BJU Int"},{"issue":"6","key":"1238_CR46","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1590\/s1677-5538.Ibju.2015.0588","volume":"42","author":"ME Westerman","year":"2016","unstructured":"Westerman ME, Boorjian SA, Linder BJ. Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: a contemporary evaluation. Int Braz J Urol. 2016;42(6):1144\u20139. https:\/\/doi.org\/10.1590\/s1677-5538.Ibju.2015.0588.","journal-title":"Int Braz J Urol"},{"issue":"3","key":"1238_CR47","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/s0022-5347(17)45009-9","volume":"136","author":"LR Kavoussi","year":"1986","unstructured":"Kavoussi LR, Gelstein LD, Andriole GL. Encephalopathy and an elevated serum aluminum level in a patient receiving intravesical alum irrigation for severe urinary hemorrhage. J Urol. 1986;136(3):665\u20137. https:\/\/doi.org\/10.1016\/s0022-5347(17)45009-9.","journal-title":"J Urol"},{"issue":"1","key":"1238_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/s0272-6386(12)80719-0","volume":"21","author":"M Perazella","year":"1993","unstructured":"Perazella M, Brown E. Acute aluminum toxicity and alum bladder irrigation in patients with renal failure. Am J Kidney Dis. 1993;21(1):44\u20136. https:\/\/doi.org\/10.1016\/s0272-6386(12)80719-0.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1238_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0090-4295(92)90479-g","volume":"40","author":"I Singh","year":"1992","unstructured":"Singh I, Laungani GB. Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage. Urology. 1992;40(3):227\u20139. https:\/\/doi.org\/10.1016\/0090-4295(92)90479-g.","journal-title":"Urology"},{"issue":"6","key":"1238_CR50","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/s0002-9343(88)80037-8","volume":"85","author":"MJ Kane","year":"1988","unstructured":"Kane MJ, Silverman LR, Rand JH, Paciucci PA, Holland JF. Myonecrosis as a complication of the use of Epsilon amino-caproic acid: a case report and review of the literature. Am J Med. 1988;85(6):861\u20133. https:\/\/doi.org\/10.1016\/s0002-9343(88)80037-8.","journal-title":"Am J Med"},{"issue":"1","key":"1238_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5414\/cnp58063","volume":"58","author":"G Manjunath","year":"2002","unstructured":"Manjunath G, Fozailoff A, Mitcheson D, Sarnak MJ. Epsilon-aminocaproic acid and renal complications: case report and review of the literature. Clin Nephrol. 2002;58(1):63\u20137. https:\/\/doi.org\/10.5414\/cnp58063.","journal-title":"Clin Nephrol"},{"issue":"1","key":"1238_CR52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/0090-4295(84)90390-x","volume":"24","author":"J Geltzeiler","year":"1984","unstructured":"Geltzeiler J, Schwartz D. Obstruction of solitary kidney due to epsilon-aminocaproic-acid-induced fibrin clot formation. Urology. 1984;24(1):64\u20136. https:\/\/doi.org\/10.1016\/0090-4295(84)90390-x.","journal-title":"Urology"},{"issue":"10","key":"1238_CR53","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/eye.2008.410","volume":"23","author":"I Rahman","year":"2009","unstructured":"Rahman I, Said D, Maharajan V, Dua H. Amniotic membrane in ophthalmology: indications and limitations. Eye. 2009;23(10):1954\u201361.","journal-title":"Eye"},{"issue":"11","key":"1238_CR54","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.ophtha.2005.05.022","volume":"112","author":"A Tamhane","year":"2005","unstructured":"Tamhane A, Vajpayee RB, Biswas NR, Pandey RM, Sharma N, Titiyal JS, et al. Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns. Ophthalmology. 2005;112(11):1963\u20139.","journal-title":"Ophthalmology"},{"issue":"4","key":"1238_CR55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/ICU.0b013e32833a8da2","volume":"21","author":"R Fish","year":"2010","unstructured":"Fish R, Davidson RS. Management of ocular thermal and chemical injuries, including amniotic membrane therapy. Curr Opin Ophthalmol. 2010;21(4):317\u201321.","journal-title":"Curr Opin Ophthalmol"},{"issue":"11","key":"1238_CR56","doi-asserted-by":"publisher","first-page":"E402","DOI":"10.5489\/cuaj.8441","volume":"17","author":"S Wittenberg","year":"2023","unstructured":"Wittenberg S, Madan R, Liaw A, Lucas S, Hamada A, Dhar N. Amniotic bladder therapy in patients with recalcitrant interstitial cystitis and bladder pain syndrome. Can Urol Assoc J. 2023;17(11):E402\u20134. https:\/\/doi.org\/10.5489\/cuaj.8441.","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"1238_CR57","first-page":"11607","volume":"30","author":"C Radoiu","year":"2023","unstructured":"Radoiu C, Jeberaeel J, Madan R, Vaishampayan N, Lucas S, Hamada A, et al. A preliminary report assessing the feasibility and effectiveness of amniotic bladder therapy in patients with chronic radiation cystitis. Can J Urol. 2023;30(4):11607\u201312.","journal-title":"Can J Urol"},{"key":"1238_CR58","unstructured":"Grujic RDD, Epinephrine. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482160\/ (2023). Accessed 2024."},{"key":"1238_CR59","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.urology.2023.02.005","volume":"175","author":"YC Chow","year":"2023","unstructured":"Chow YC, Hsu WH, Chen M, Lin WC, Chiu AW. Safety and Efficacy of Intravesical Epinephrine Instillation in patients with intractable lower urinary Tract Hematuria - A Novel Approach. Urology. 2023;175:216\u201322. https:\/\/doi.org\/10.1016\/j.urology.2023.02.005.","journal-title":"Urology"},{"issue":"2","key":"1238_CR60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/end.2018.0028","volume":"33","author":"P Bove","year":"2019","unstructured":"Bove P, Iacovelli V, Tirindelli MC, Bianchi D, Flammia GP, Cipriani C, et al. Endoscopic Intravesical Fibrin glue application in the treatment of Refractory Hemorrhagic Radiation Cystitis: a single cohort pilot study. J Endourol. 2019;33(2):93\u20138. https:\/\/doi.org\/10.1089\/end.2018.0028.","journal-title":"J Endourol"},{"issue":"5","key":"1238_CR61","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1464-410X.2011.10550.x","volume":"109","author":"Y Shao","year":"2012","unstructured":"Shao Y, Lu GL, Shen ZJ. Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU Int. 2012;109(5):691\u20134. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10550.x.","journal-title":"BJU Int"},{"key":"1238_CR62","doi-asserted-by":"publisher","unstructured":"Moring N, Barrett S, Peterson AC, Inouye BM. Pelvic extirpative surgery for the end-stage irradiated bladder. Cancers (Basel). 2023;15(17). https:\/\/doi.org\/10.3390\/cancers15174238.","DOI":"10.3390\/cancers15174238"},{"issue":"7","key":"1238_CR63","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/bju.12291","volume":"112","author":"H Payne","year":"2013","unstructured":"Payne H, Adamson A, Bahl A, Borwell J, Dodds D, Heath C, et al. Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int. 2013;112(7):885\u201397. https:\/\/doi.org\/10.1111\/bju.12291.","journal-title":"BJU Int"},{"issue":"6","key":"1238_CR64","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/s0090-4295(99)80349-5","volume":"46","author":"C Ippoliti","year":"1995","unstructured":"Ippoliti C, Przepiorka D, Mehra R, Neumann J, Wood J, Claxton D, et al. Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology. 1995;46(6):811\u20135. https:\/\/doi.org\/10.1016\/s0090-4295(99)80349-5.","journal-title":"Urology"},{"issue":"4","key":"1238_CR65","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/s0022-5347(17)36192-x","volume":"149","author":"LA Levine","year":"1993","unstructured":"Levine LA, Jarrard DF. Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine. J Urol. 1993;149(4):719\u201323. https:\/\/doi.org\/10.1016\/s0022-5347(17)36192-x.","journal-title":"J Urol"},{"key":"1238_CR66","unstructured":"Araya AATY, Tacrolimus. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544318\/ (2023). Accessed 2024."},{"issue":"4","key":"1238_CR67","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.eururo.2008.03.013","volume":"54","author":"AK Ebert","year":"2008","unstructured":"Ebert AK, R\u00f6sch WH, Vogt T. Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol. 2008;54(4):932\u20137. https:\/\/doi.org\/10.1016\/j.eururo.2008.03.013.","journal-title":"Eur Urol"},{"issue":"10","key":"1238_CR68","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s11255-015-1098-6","volume":"47","author":"CN Dave","year":"2015","unstructured":"Dave CN, Chaus F, Chancellor MB, Lajness M, Peters KM. Innovative use of intravesical tacrolimus for hemorrhagic radiation cystitis. Int Urol Nephrol. 2015;47(10):1679\u201381. https:\/\/doi.org\/10.1007\/s11255-015-1098-6.","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"1238_CR69","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.juro.2015.03.108","volume":"194","author":"BR Rajaganapathy","year":"2015","unstructured":"Rajaganapathy BR, Janicki JJ, Levanovich P, Tyagi P, Hafron J, Chancellor MB, et al. Intravesical Liposomal Tacrolimus protects against Radiation Cystitis Induced by 3-Beam targeted bladder Radiation. J Urol. 2015;194(2):578\u201384. https:\/\/doi.org\/10.1016\/j.juro.2015.03.108.","journal-title":"J Urol"},{"issue":"3","key":"1238_CR70","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5152\/tud.2016.38445","volume":"42","author":"BD Montgomery","year":"2016","unstructured":"Montgomery BD, Boorjian SA, Ziegelmann MJ, Joyce DD, Linder BJ. Intravesical silver nitrate for refractory hemorrhagic cystitis. Turk J Urol. 2016;42(3):197\u2013201. https:\/\/doi.org\/10.5152\/tud.2016.38445.","journal-title":"Turk J Urol"},{"issue":"2","key":"1238_CR71","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0020-7292(93)90626-8","volume":"42","author":"AK Dewan","year":"1993","unstructured":"Dewan AK, Mohan GM, Ravi R. Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix. Int J Gynaecol Obstet. 1993;42(2):131\u20135. https:\/\/doi.org\/10.1016\/0020-7292(93)90626-8.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"1238_CR72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/iju.14130","volume":"27","author":"L Villeirs","year":"2020","unstructured":"Villeirs L, Tailly T, Ost P, Waterloos M, Decaestecker K, Fonteyne V, et al. Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: systematic review of the recent literature. Int J Urol. 2020;27(2):98\u2013107. https:\/\/doi.org\/10.1111\/iju.14130.","journal-title":"Int J Urol"},{"issue":"4","key":"1238_CR73","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrurol.2010.23","volume":"7","author":"SG Smit","year":"2010","unstructured":"Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010;7(4):206\u201314. https:\/\/doi.org\/10.1038\/nrurol.2010.23.","journal-title":"Nat Rev Urol"},{"issue":"11","key":"1238_CR74","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/s1470-2045(19)30494-2","volume":"20","author":"N Oscarsson","year":"2019","unstructured":"Oscarsson N, M\u00fcller B, Ros\u00e9n A, Lodding P, M\u00f6lne J, Giglio D, et al. Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2\u20133 trial. Lancet Oncol. 2019;20(11):1602\u201314. https:\/\/doi.org\/10.1016\/s1470-2045(19)30494-2.","journal-title":"Lancet Oncol"},{"issue":"10","key":"1238_CR75","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/sj.bmt.1703954","volume":"31","author":"E Gin\u00e9","year":"2003","unstructured":"Gin\u00e9 E, Rovira M, Real I, Burrel M, Monta\u00f1a J, Carreras E, et al. Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transpl. 2003;31(10):923\u20135. https:\/\/doi.org\/10.1038\/sj.bmt.1703954.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"1238_CR76","first-page":"236","volume":"2","author":"JF Ward","year":"2000","unstructured":"Ward JF, Velling TE. Transcatheter therapeutic embolization of genitourinary pathology. Rev Urol. 2000;2(4):236\u201352.","journal-title":"Rev Urol"},{"key":"1238_CR77","doi-asserted-by":"publisher","unstructured":"Pozzi Mucelli F, Pozzi Mucelli RA, Marrocchio C, Tollot S, Cova MA. Endovascular interventional Radiology of the urogenital tract. Med (Kaunas). 2021;57(3). https:\/\/doi.org\/10.3390\/medicina57030278.","DOI":"10.3390\/medicina57030278"},{"issue":"5","key":"1238_CR78","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.juro.2010.01.003","volume":"183","author":"A Delgal","year":"2010","unstructured":"Delgal A, Cercueil J-P, Koutlidis N, Michel F, Kermarrec I, Mourey E, et al. Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage. J Urol. 2010;183(5):1947\u201353. https:\/\/doi.org\/10.1016\/j.juro.2010.01.003.","journal-title":"J Urol"},{"issue":"2","key":"1238_CR79","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.diii.2015.06.020","volume":"97","author":"M Korkmaz","year":"2016","unstructured":"Korkmaz M, \u015eanal B, Aras B, Bozkaya H, \u00c7\u0131nar C, G\u00fcneyli S, et al. The short- and long-term effectiveness of transcatheter arterial embolization in patients with intractable hematuria. Diagn Interv Imaging. 2016;97(2):197\u2013201. https:\/\/doi.org\/10.1016\/j.diii.2015.06.020.","journal-title":"Diagn Interv Imaging"},{"issue":"5","key":"1238_CR80","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5152\/tud.2023.22224","volume":"49","author":"A Hekimoglu","year":"2023","unstructured":"Hekimoglu A, Ergun O, Hekimoglu B. Selective transarterial embolization for intractable Hematuria due to bladder carcinomas: a single-center experience. Urol Res Pract. 2023;49(5):334\u20137. https:\/\/doi.org\/10.5152\/tud.2023.22224.","journal-title":"Urol Res Pract"},{"issue":"4","key":"1238_CR81","first-page":"114","volume":"48","author":"M Nitta","year":"2023","unstructured":"Nitta M, Tazawa M, Naruse J, Takeda K, Oda K, Uchida T, et al. Two cases of Intractable Radiation-Induced Hemorrhagic Cystitis treated with transcatheter embolization. Tokai J Exp Clin Med. 2023;48(4):114\u20136.","journal-title":"Tokai J Exp Clin Med"},{"issue":"2","key":"1238_CR82","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/s0022-5347(17)34969-8","volume":"151","author":"PR Sieber","year":"1994","unstructured":"Sieber PR. Bladder necrosis secondary to pelvic artery embolization: case report and literature review. J Urol. 1994;151(2):422. https:\/\/doi.org\/10.1016\/s0022-5347(17)34969-8.","journal-title":"J Urol"},{"issue":"1","key":"1238_CR83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s42155-018-0043-z","volume":"1","author":"A Tarkhanov","year":"2018","unstructured":"Tarkhanov A, Bartal G, Druzhin S, Shakhbazyan R, Grebenev E, Kartashov M. Bladder wall and surrounding tissue necrosis following bilateral superselective embolization of internal iliac artery branches due to uncontrollable haematuria related to bladder tumor: case report. CVIR Endovasc. 2018;1(1):34. https:\/\/doi.org\/10.1186\/s42155-018-0043-z.","journal-title":"CVIR Endovasc"},{"issue":"1","key":"1238_CR84","first-page":"Doc15","volume":"3","author":"M Zenker","year":"2008","unstructured":"Zenker M. Argon plasma coagulation. GMS Krankenhhyg Interdiszip. 2008;3(1):Doc15.","journal-title":"GMS Krankenhhyg Interdiszip"},{"issue":"3","key":"1238_CR85","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1464-410X.2006.06293.x","volume":"98","author":"MP Wines","year":"2006","unstructured":"Wines MP, Lynch WD. A new minimally invasive technique for treating radiation cystitis: the argon-beam coagulator. BJU Int. 2006;98(3):610\u20132. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06293.x.","journal-title":"BJU Int"},{"issue":"7","key":"1238_CR86","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/jjco\/hyu066","volume":"44","author":"S Suzuki","year":"2014","unstructured":"Suzuki S, Chino A, Fukui I, Hayashi T, Kozuka T, Suganuma T, et al. Successful use of endoscopic argon plasma coagulation for hemorrhagic radiation cystitis: a case report. Jpn J Clin Oncol. 2014;44(7):692\u20135. https:\/\/doi.org\/10.1093\/jjco\/hyu066.","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"1238_CR87","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.purol.2023.07.009","volume":"33","author":"L Le Bloa","year":"2023","unstructured":"Le Bloa L, Ait Said K, Pradere B, Tillou X, Waeckel T. Photocoagulation with GREENLIGHT\u00a9 laser in radiation-induced haemorrhagic cystitis: results of a single-center series. Prog Urol. 2023;33(10):488\u201391. https:\/\/doi.org\/10.1016\/j.purol.2023.07.009.","journal-title":"Prog Urol"},{"issue":"11","key":"1238_CR88","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.urolonc.2021.05.038","volume":"39","author":"I Tachibana","year":"2021","unstructured":"Tachibana I, Calaway AC, Abedali Z, Szymanski KM, Mellon MJ, Masterson TA, et al. Definitive surgical therapy for refractory radiation cystitis: evaluating effectiveness, tolerability, and extent of surgical approach. Urol Oncol. 2021;39(11):789. https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.038. e1-.e7.","journal-title":"Urol Oncol"},{"issue":"1","key":"1238_CR89","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.urology.2006.01.051","volume":"68","author":"BR Konety","year":"2006","unstructured":"Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology. 2006;68(1):58\u201364. https:\/\/doi.org\/10.1016\/j.urology.2006.01.051.","journal-title":"Urology"},{"key":"1238_CR90","doi-asserted-by":"publisher","first-page":"e38362","DOI":"10.2196\/38362","volume":"12","author":"C Helissey","year":"2023","unstructured":"Helissey C, Cavallero S, Mondot S, Parnot C, Yssaad H, Becherirat S, et al. Correlation between serum and urine biomarkers and the intensity of Acute Radiation Cystitis in patients treated with Radiation Therapy for localized prostate Cancer: protocol for the Radiotoxicity bladder biomarkers (RABBIO) Study. JMIR Res Protoc. 2023;12:e38362. https:\/\/doi.org\/10.2196\/38362.","journal-title":"JMIR Res Protoc"},{"issue":"12","key":"1238_CR91","doi-asserted-by":"publisher","first-page":"e54011","DOI":"10.1016\/j.urolonc.2022.09.006","volume":"40","author":"BK Wallace","year":"2022","unstructured":"Wallace BK, Gillespie AM, Moran GW, Smigelski MB, Anderson CB. Heterogeneity in the pharmacological management of radiation-induced hemorrhagic cystitis. Urol Oncol. 2022;40(12):e54011\u201317. https:\/\/doi.org\/10.1016\/j.urolonc.2022.09.006.","journal-title":"Urol Oncol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-024-01238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-024-01238-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-024-01238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:02:55Z","timestamp":1767985375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-024-01238-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1238"],"URL":"https:\/\/doi.org\/10.1007\/s11934-024-01238-0","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"13 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and Human and Animal Rights Statements"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1"}}